Studies about ketamine have been rolling in over the past few years. Some important notes:<p>1. Almost all of these are looking at IV ketamine at very low doses (lower than anestheic or "recreational" dosing).<p>2. Like most of these trials, this is also a small trial (18 patients).<p>3. This was an adjunctive therapy, for patients who were on stable dosing of lithium or valproic acid which are first line for bipolar disorder.<p>Cool stuff, but preliminary at this point. Hopefully it will lead to options that are safer, more convenient, and with less abuse potential but maintain the rapid response that appears to be related to glutamatergic activity.